Immunocore Holdings PLC (IMCR)
32.28
+0.16
(+0.50%)
USD |
NASDAQ |
Nov 22, 16:00
32.22
-0.06
(-0.19%)
After-Hours: 20:00
Immunocore Holdings Total Liabilities (Quarterly): 706.81M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 706.81M |
| June 30, 2024 | 664.23M |
| March 31, 2024 | 634.45M |
| December 31, 2023 | 228.16M |
| September 30, 2023 | 210.56M |
| June 30, 2023 | 205.70M |
| March 31, 2023 | 193.75M |
| December 31, 2022 | 187.86M |
| September 30, 2022 | 167.34M |
| Date | Value |
|---|---|
| June 30, 2022 | 158.79M |
| March 31, 2022 | 155.97M |
| December 31, 2021 | 175.76M |
| September 30, 2021 | 173.01M |
| June 30, 2021 | 181.13M |
| March 31, 2021 | 186.04M |
| December 31, 2020 | 193.31M |
| September 30, 2020 | 148.31M |
| December 31, 2019 | 224.05M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
148.31M
Minimum
Sep 2020
706.81M
Maximum
Sep 2024
266.40M
Average
190.59M
Median
Total Liabilities (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 237.45M |
| Biodexa Pharmaceuticals PLC | 6.628M |
| Verona Pharma PLC | 251.33M |
| NuCana PLC | 20.58M |
| Autolus Therapeutics PLC | 350.52M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.085B |
| Shareholders Equity (Quarterly) | 377.83M |
| Debt to Equity Ratio | 1.161 |
| Current Ratio | 3.778 |
| Net Debt Paydown Yield | -5.02% |